Provided by Tiger Fintech (Singapore) Pte. Ltd.

AIM VACCINE

4.100
-0.930-18.49%
Volume:9.82M
Turnover:41.38M
Market Cap:5.03B
PE:-3.57
High:4.780
Open:4.780
Low:4.020
Close:5.030
Loading ...

AIM Vaccine's Rabbies Vaccine Gets NMPA Nod for Clinical Trials; Shares Slide 17%

MT Newswires Live
·
7 hours ago

Private companies are AIM Vaccine Co., Ltd.'s (HKG:6660) biggest owners and were hit after market cap dropped HK$400m

Simply Wall St.
·
04 Mar

AIM Vaccine Eyes HK$74.7 Million from Share Placement; Shares Slide 12%

MT Newswires Live
·
28 Feb

BUZZ-China's AIM Vaccine slumps on discounted share sale

Reuters
·
28 Feb

BRIEF-Aim Vaccine Co Announces Placing Of 15.5 Million Shares

Reuters
·
28 Feb

AIM Vaccine Co Ltd - Placing of 15.5 Mln Shares at HK$5.01 per Share

THOMSON REUTERS
·
28 Feb

BUZZ-China's AIM jumps on approval of vaccine's clinical trial in US

Reuters
·
27 Feb

AIM Vaccine Gets US FDA Clinical Trial Nod for Respiratory Syncytial Virus Jab

MT Newswires Live
·
27 Feb

BRIEF-AIM Vaccine Says Clinical Trial Of MRNA Respiratory Syncytial Virus Vaccines Approved By FDA

Reuters
·
26 Feb

AIM Vaccine Co Ltd - Clinical Trial of Mrna Respiratory Syncytial- Virus Vaccines Approved by FDA

THOMSON REUTERS
·
26 Feb

AIM Vaccine Submits US Clinical Trial Application for Shingles Jab

MT Newswires Live
·
24 Feb

BRIEF-AIM Vaccine Says Fully Integrates Deepseek In All Business Scenarios

Reuters
·
23 Feb

AIM Vaccine Says Co Fully Integrates Deepseek in All Business Scenarios, Covering R&D, Production, Sales

THOMSON REUTERS
·
23 Feb

AIM Vaccine Submits Clinical Trial Application for mRNA Shingles Vaccine to Chinese Regulator

MT Newswires Live
·
12 Feb

AIM Vaccine Mrna Rsv Vaccine Submits for Clinical Trials in the U.S.

THOMSON REUTERS
·
06 Feb

AIM Submits Clinical Trial Application to US FDA for mRNA RSV Vaccine

MT Newswires Live
·
05 Feb